Population
A 43-year-old man presenting with pulmonary embolism and 7 other family members with suspected antithrombin…
Design
Case_series
Authors
Loading...
Supports functional AT III assay in heparin-resistant thrombosis; extends known antithrombin variants but leaves open prevalence and clinical impact.
Identifies a novel hereditary abnormal antithrombin III variant (AT III Geneva) characterized by defective heparin cofactor activity, which can present clinically as pulmonary embolism with increased heparin requirements.
Moerloose et al. (1987) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: